A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis

• DOI: 10.1155/2018/7875929
• Publication Date: 2018-03-29T19:31:11Z
• Authors: Haruhiko Yamazaki; Hiroyuki Iwasaki; Toshinari Yamashita; Tatsuya Yoshida; Nobuyasu Suganuma; Takashi Yamanaka; Katsuhiko Masudo; Hirotaka Nakayama; Kaori Kohagura; Yasushi Rino; Munetaka Masuda
• Keywords: Lenvatinib; Anaplastic thyroid cancer; Pleurodesis

A 63-year-old man was diagnosed with multiple lung metastases from anaplastic thyroid cancer and received lenvatinib. Follow-up computed tomography on day 34 of lenvatinib treatment showed pneumothorax. The pneumothorax temporarily improved chest drainage. However, pleurodesis performed to treat a relapse the Pneumothorax during chemotherapy for malignant tumor is considered relatively rare complication. This case first documentation that may develop treatment. possible development should be when used in patients metastasis.